KRP (kinase-related protein), also known as telokin, has been proposed to inhibit smooth muscle contractility by inhibiting the phosphorylation of the rMLC (regulatory myosin light chain) by the Ca 2+ -activated MLCK (myosin light chain kinase). Using the phosphatase inhibitor microcystin, we show in the present study that KRP also inhibits Ca 2+ -independent rMLC phosphorylation and smooth muscle contraction mediated by novel Ca 2+ -independent rMLC kinases. Incubating KRP-depleted Triton-skinned taenia coli with microcystin at pCa>8 induced a slow contraction reaching 90 % of maximal force (F max ) at pCa 4.5 after ∼ 25 min. Loading the fibres with KRP significantly slowed down the force development, i.e. the time to reach 50 % of F max was increased from 8 min to 35 min. KRP similarly inhibited rMLC phosphorylation of HMM (heavy meromyosin) in vitro by MLCK or by the constitutively active MLCK fragment (61K-MLCK) lacking the myosin-docking KRP domain. A C-terminally truncated KRP defective in myosin binding inhibited neither force nor HMM phosphorylation. Phosphorylated KRP inhibited the rMLC phosphorylation of HMM in vitro and Ca 2+ -insensitive contractions in fibres similar to unphosphorylated KRP, whereby the phosphorylation state of KRP was not altered in the fibres. We conclude that (i) KRP inhibits not only MLCKinduced contractions, but also those elicited by Ca 2+ -independent rMLC kinases; (ii) phosphorylation of KRP does not modulate this effect; (iii) binding of KRP to myosin is essential for this inhibition; and (iv) KRP inhibition of rMLC phosphorylation is most probably due to the shielding of the phosphorylation site on the rMLC.
KRP (kinase-related protein), also known as telokin, has been proposed to inhibit smooth muscle contractility by inhibiting the phosphorylation of the rMLC (regulatory myosin light chain) by the Ca 2+ -activated MLCK (myosin light chain kinase). Using the phosphatase inhibitor microcystin, we show in the present study that KRP also inhibits Ca 2+ -independent rMLC phosphorylation and smooth muscle contraction mediated by novel Ca 2+ -independent rMLC kinases. Incubating KRP-depleted Triton-skinned taenia coli with microcystin at pCa>8 induced a slow contraction reaching 90 % of maximal force (F max ) at pCa 4.5 after ∼ 25 min. Loading the fibres with KRP significantly slowed down the force development, i.e. the time to reach 50 % of F max was increased from 8 min to 35 min. KRP similarly inhibited rMLC phosphorylation of HMM (heavy meromyosin) in vitro by MLCK or by the constitutively active MLCK fragment (61K-MLCK) lacking the myosin-docking KRP domain. A C-terminally truncated KRP defective in myosin binding inhibited neither force nor HMM phosphorylation. Phosphorylated KRP inhibited the rMLC phosphorylation of HMM in vitro and Ca 2+ -insensitive contractions in fibres similar to unphosphorylated KRP, whereby the phosphorylation state of KRP was not altered in the fibres. We conclude that (i) KRP inhibits not only MLCKinduced contractions, but also those elicited by Ca 2+ -independent rMLC kinases; (ii) phosphorylation of KRP does not modulate this effect; (iii) binding of KRP to myosin is essential for this inhibition; and (iv) KRP inhibition of rMLC phosphorylation is most probably due to the shielding of the phosphorylation site on the rMLC. 19 of the rMLC [regulatory MLC (myosin light chain)] catalysed by the Ca 2+ -calmodulin-activated MLCK (MLC kinase) is a prerequisite for the activation of smooth muscle actomyosin MgATPase and contraction [1] . Dephosphorylation of Ser 19 by MLCP (rMLC phosphatase) results in myosin inactivation and relaxation [2] . The level of rMLC phosphorylation and, hence, of force is determined by the ratio of MLCK to MLCP activity. A rise in the cytosolic free Ca 2+ concentration ([Ca 2+ ] i ) in response to contractile stimuli is the major determinant of rMLC phosphorylation and, hence, of smooth muscle contraction. However, many contractile agonists increase force and rMLC phosphorylation further at a given [Ca 2+ ] i , leading to a leftward shift in the force-[Ca 2+ ] relationship, a phenomenon now known as Ca 2+ -sensitization [3, 4] . Conversely, relaxant agonists, which act through a rise in the intracellular cyclic nucleotide levels, relax smooth muscle not only by a decrease in [Ca 2+ ] i , but often also by decreasing the Ca 2+ -sensitivity of rMLC phosphorylation. Ca 2+ -sensitization has been mainly attributed to G-proteinmediated inhibition of MLCP which shifts the balance in favour of the rMLC phosphorylation reaction [3] . It is generally believed that the kinase responsible for phosphorylation of rMLC under these conditions is MLCK, which is partially activated at the prevailing [Ca 2+ ] i . However, evidence has been accumulating that rMLC can also be phosphorylated in a Ca 2+ -and MLCK-independent manner by distinct protein kinases which are activated in response to certain agonists [5] [6] [7] [8] [9] [10] . Thus the left-ward shift in the force- [Ca 2+ ] relationship may reflect a concerted action of partially activated MLCK and non-canonical Ca 2+ -independent rMLC kinases. Out of several putative Ca 2+ -independent rMLC kinases (reviewed in [11] ), the ZIP (MYPT1-associated zipper-interacting) kinase [12] and the myofilament-associated ILK (integrin-linked kinase), which is spatially distinct from membrane-bound ILK [10] , emerged as bona fide candidates. In contrast with MLCK, which specifically phosphorylates Ser 19 , these non-canonical rMLC kinases phosphorylate Ser KRP (kinase-related protein), also known as telokin, decreases Ca 2+ -sensitivity, thereby contributing to ∼ 50 % of cGMPinduced Ca 2+ -independent relaxation in ileal smooth muscle [16] . However, the mechanism by which KRP decreases Ca 2+ -sensitivity is not understood. In particular, it is not known whether it can antagonize Ca 2+ -sensitization induced by the non-canonical Ca 2+ -independent rMLC kinases. KRP, a small acidic protein, was discovered by Hartshorne and colleagues [17] and was later shown to be a smoothmuscle-specific protein whose sequence is identical with the C-terminal domain of sm-MLCK (smooth muscle MLCK) [18] [19] [20] . It is independently transcribed through a promoter located in an intron of the mylk1 gene, and is expressed in very high levels in intestinal, urinary and reproductive tracts, and at lower levels in vascular smooth muscle [18, 19, 21, 22] . KRP is devoid of the calmodulin-and nucleotide-binding sites of MLCK, as well as its catalytic domain. The crystal structure showed an immunoglobulin-like fold bordered by a C-terminal 19-aminoacid and a N-terminal 35-amino-acid sequence which were not resolved in the crystal structure, suggesting that these segments are highly flexible and may be of relevance for the function of KRP [23] . KRP binds at the acidic C-terminus to the neck region of unphosphorylated myosin, but not to phosphorylated myosin [24] , and thereby promotes the extended conformation of myosin and filament formation [25, 26] . The flexible N-terminus harbours several phosphorylation sites, including a PKA (protein kinase A)/PKG (Ser 13 ) and a MAPK (mitogen-activated protein kinase) phosphorylation site (Ser 19 ) [22, [27] [28] [29] [30] . In intact ileum, forskolin leads to a significant phosphorylation of Ser 13 , which correlates with relaxation, whereas phosphorylation of Ser 19 increases only a little in response to PKC-mediated activation of MAPK [27] .
INTRODUCTION

Phosphorylation of Ser
In permeabilized smooth muscle, KRP inhibited submaximal Ca 2+ -activated force, i.e. decreased Ca 2+ -sensitivity [31] and accelerated relaxation [32] . The relaxing effect was potentiated by cGMP-mediated phosphorylation of KRP, or by a S13D phosphorylation-mimicking mutation in KRP [21, 30, 32] . The relaxing effect of KRP could be due to either inhibition of MLCK or increasing the activity of MLCP. To determine the MLCK activity in the skinned fibres, ATP[S] (adenosine 5 -[γ -thio]triphosphate) was used as a substrate because thiophosphorylated rMLCs are not dephosphorylated by MLCP [16] . As a measure of MLCP activity, the rate of dephosphorylation of prephosphorylated rMCL was used [32] . KRP did not alter the rate of thiophosphorylation, but increased the rate of dephosphorylation of rMLC. Therefore the authors [16] proposed that KRP relaxes smooth muscle by increasing the activity of MLCP by an as yet undefined mechanism. Consistent with these experiments, the rate of dephosphorylation of a so-called native myosin preparation which contains MLCK, calmodulin and MLCP was increased by KRP under cell-free conditions [31] .
On the other hand, a substantial body of biochemical evidence has shown that KRP attenuates the rate of MLCK-catalysed rMLC phosphorylation of intact myosin [24, 26, 31, 33] , and the soluble fragment of myosin HMM (heavy meromyosin) [24] , but not of isolated rMLC [18, 33] . From this it was concluded that (i) formation of myosin filaments is not required for the inhibition of phosphorylation, and (ii) KRP does not interact with the catalytic core of MLCK in a functionally relevant manner. The C-termini of KRP and MLCK share a common docking site on the myosin S1-S2 junction which is independent of the catalytic interaction of MLCK with rMLC [24] . Because KRP binding affects only the K m , but not the V max , value of the phosphorylation reaction, it was proposed that KRP inhibits the phosphate transfer on to rMLC by competing with MLCK for docking binding to myosin [34] . Indeed, KRP displaces MLCK from smooth muscle myosin [25, 35] , and the binding of KRP to myosin is critical for the inhibition of rMLC phosphorylation [29] . This mechanism, i.e. competition between KRP and MLCK for docking to myosin, is therefore specific to the dedicated MLCK and would not apply to rMLC kinases that do not use the KRP domain-mediated docking on to the substrate.
An attractive hypothesis is that KRP, because of binding in the vicinity of rMLC, limits the accessibility of Ser 19 and thereby inhibits rMLC phosphorylation and contraction induced by non-canonical rMLC kinases. The aim of the present study was therefore to determine whether KRP inhibits (i) rMLC phosphorylation of HMM induced by the constitutively active proteolytic fragment of MLCK, which lacks the KRP domain and, hence, does not bind to myosin, and (ii) Ca 2+ -and MLCKindependent contractions in Triton-skinned fibres. To elicit Ca 2+ -and MLCK-independent contractions, the type 1 and type 2A phosphatase inhibitor microcystin was employed as it has been reported by several laboratories that inhibition of MLCP by microcystin unmasks the action of the non-canonical rMLC kinases in permeabilized vascular [5, 6, 12, 36] and ileal smooth muscle [7, 8] . In the present study, we show that KRP inhibits the microcystin-induced Ca 2+ -independent sustained contraction and rMLC phosphorylation in skinned fibres. Likewise, it inhibits rMLC phosphorylation of HMM by the constitutively active fragment of MLCK (61K-MLCK), i.e. by a mechanism different from the displacement of MLCK from myosin. We further show that this effect is not modulated by phosphorylation of KRP with PKA, MAPK or both kinases, whereas it critically depends on the binding of KRP to myosin. From these experiments, we conclude that KRP is a general inhibitor of the phosphorylation reaction catalysed by the Ca 2+ -dependent MLCK and the non-canonical rMLC kinases.
EXPERIMENTAL
Materials
The polyclonal antibodies against KRP and KRP phosphorylated at Ser 13 and Ser 19 have been described previously [22, 27] . The anti-rMLC antibody (clone Y-21) and microcystin-LR were from Sigma. The polyclonal anti-rMLC antibody (MRLC3, catalogue number 10324-1-AP) was from Proteintech Group. The PKA catalytic subunit, wortmannin, Y-27632, okadaic acid and staurosporine were purchased from Calbiochem. Alexa Fluor ® 488 C 5 maleimide, Alexa Fluor ® 488 succinimidyl ester and Alexa Fluor ® 555 phalloidin were from Invitrogen. DAPI (4 ,6-diamidino-2-phenylindole) was purchased from Sigma. Restriction and modifying enzymes were from New England Biolabs and Fermentas. The [γ -32 P]ATP was from the Institute of Physics and Energetics (Obninsk, Russia) and from Hartmann Analytic. Biological buffers and general chemicals were from Sigma or AppliChem.
Plasmids and molecular cloning
GST (glutathione transferase)-tagged MAPK with a molecular mass of 44 kDa (p44 erkl -MAPK) expression and activation by phosphorylation with the constitutively active His 6 -tagged MEK1 [MAPK/ERK (extracellular-signal-regulated kinase) kinase 1] were performed as described previously [27] . The plasmid pET22-b+/DD-hKRP, expressing the phosphorylation-mimicking KRP mutant S13D,S19D was generated using the pET22-b+/ hKRP construct encoding the full-length human KRP [27] as a template. Plasmids pET21-d(+)/chiKRP-His, pET21-d(+)/ C-chiKRP-His and pET21-d(+)/ N-chiKRP-His encoding, respectively, the full-length chicken KRP, its C-terminally truncated [ C-KRP, aa (amino acids) and Nterminally truncated ( N-KRP, aa 35-157) mutants, all containing the His 6 -tag at the C-termini, have been described previously [24] . The C-hKRP cDNA (aa 1-136 of human KRP) was amplified by PCR using 5 -TATAGATCTCCAT-GGCAATGATCTCAGGGC-3 as a forward primer and 5 -AAACTCGAGCTAAAGCTCTGCTGTGCAGGTG-3 as a reverse primer, and was subcloned into the pET28-a+ vector (Novagen) at NcoI and XhoI restriction sites. The constructs were confirmed by DNA sequencing.
Proteins
HMM [37, 38] and native 108 kDa MLCK were purified from chicken gizzards. The constitutively active fragment of MLCK (61K-MLCK, molecular mass ∼ 61 kDa) was obtained by tryptic digestion of 108 kDa MLCK, using a method described in [39] . We note that the truncated MLCK lacks the C-terminal KRP domain and possesses somewhat lower catalytic activity than the parent MLCK. Calmodulin was purified from bovine testis [40] . The other recombinant proteins were expressed in Escherichia coli strain BL21(DE3). His 6 -MEK1 and chicken His 6 -KRP were purified from bacterial lysates on TALON affinity matrices (Clontech). GST-tagged p44 erk1 MAPK was purified on glutathione-Sepharose (Amersham Pharmacia Biotech). Human recombinant non-tagged KRP proteins were purified using the method of Ito et al. [17] . KRP concentrations were determined using specific molar absorption coefficient A 1cm 0.1% 280 = 0.77 [24] . Human recombinant KRP was used in all fibre experiments, whereas in the biochemical experiments both chicken and human KRP were used as specified in the Figure legends.
Phosphorylation of KRP in vitro
The full-size human KRP was completely phosphorylated by PKA and/or p44 erkl -MAPK as described in [27] . The extent of phosphorylation was confirmed by the shift of PKA-and MAPKphosphorylated KRP in urea-glycerol gels [41] or SDS/PAGE [42] respectively. Phosphorylated KRP was purified from PKA using ion-exchange chromatography on cellulose phosphate (Sigma) in 15 mM Mes (pH 6.5), 0.1 mM PMSF and 1 mM DTT (dithiothreitol). Under these conditions, PKA bound to the column and KRP was eluted in the flow-through. Glutathione-Sepharose and TALON affinity matrices respectively were used to remove the GST-tagged p44 erkl -MAPK and His 6 -MEK1. The efficacy of these procedures was checked by adding unphosphorylated human C-KRP as a substrate for any remaining kinase to the columnpurified phospho-KRP. The KRP proteins, i.e. the full-length KRP and C-KRP which have different electrophoretic mobilities, were separated by SDS/PAGE followed by immunoblotting with phospho-specific antibodies against phospho-Ser 13 and phospho-Ser 19 KRP as described below. No immunoreactivity was associated with the C-KRP band, indicating that no kinase activities remained in the phosphorylated KRP preparations.
HMM phosphorylation by MLCK
HMM (4 μM) was phosphorylated by 10 nM of 108 kDa MLCK or 40 nM of 61K-MLCK at 30
• C in the buffer containing 10 mM Mops (pH 7.0), 1 mM MgCl 2 , 0.1 mM EGTA, 20 mM or 150 mM NaCl, 1 mM DTT, 0.1 mM PMSF and 0.1-0.5 mM ATP, in the presence or absence of 20 μM or 50 μM full-size unphosphorylated KRP or KRP phosphorylated by PKA and/or MAPK. When 108 kDa MLCK was used, 300 nM calmodulin and 0.5 mM Ca 2+ were also added. Equal aliquots (5 ml) of the reaction mixture were withdrawn at different times and their composition was analysed by either SDS/PAGE or urea-glycerol gels. An anti-total rMLC (MRLC3) antibody was used to determine the level of rMLC phosphorylation after the separation of phosphoand unphospho-rMLC by urea-glycerol gel electrophoresis. The antibody binding was visualized by DAB (diaminobenzidine) staining. Alternatively, phosphorylation of rMLC was conducted in the presence of 1.5-2.5 kBq/ml [γ - 32 P]ATP and visualized by autoradiography. The resultant images were scanned and quantified using the Bio-Rad GS800 calibrated densitometer and Quantity One 4.6 software. Phosphorylation levels were calculated as ratios of the phospho-rMLC signal to that of total rMLC and, in the case of radioactive experiments, they were further referenced to that of completely phosphorylated rMLC in order to obtain the phosphorylation stoichiometry. The completeness of rMLC phosphorylation was controlled by the urea gels.
Tissue preparation and force measurements
Male or female guinea pigs were anaesthetized with isofluoran and killed by exsanguination following the procedures approved by the Institutional Animal Care and Use Committee of the University of Cologne. The taenia coli was removed and permeabilized by chemical skinning with 1 % Triton X-100 for 4 h on ice, as described in [43] . The skinned fibres were stored at − 20
• C in relaxing solution containing 50 % glycerol and used within 2 weeks. The relaxing solution contained 20 mM imidazole, 7.5 mM Na 2 ATP, 10 mM magnesium acetate, 4 mM EGTA, 1 mM sodium azide, 140 units/ml creatine kinase, 10 mM creatine phosphate, 1 μM leupeptin, 2 mM DTT and 0.5 or 1 μM calmodulin [pH 6.7 at room temperature (23
] was obtained by mixing contracting and relaxing solution (contracting solution has the same composition as relaxing solution, but containing, in addition, 4 mM CaCl 2 ) in the appropriate ratio; [Ca 2+ ] was calculated as in [44] . KRP or the respective volume of KRP dialysis buffer was added to the incubation solutions as specified below.
For force measurements, the strips (∼ 0.2 mm in diameter and 5 mm in length) were mounted between a fixed post and a KG7 force transducer (Scientific Instruments) while in relaxing solution, stretched by 5 % of slack length, and allowed to equilibrate for 15-20 min. After an initial control contraction (pCa 4.5), the fibres were relaxed and incubated with the appropriate KRP species (final concentration 10 μM) or dialysis buffer (control) for 40 min. The Ca 2+ -independent contraction was elicited by the addition of 10 μM microcystin-LR (final concentration) in the continued presence of KRP or dialysis buffer (control). After recording the Ca 2+ -independent contraction, the fibres were immersed in Ca 2+ -containing contraction solution (pCa 4.5) to determine the maximum force (F max ) which was used to normalize the microcystin-induced force values.
Determination of the KRP content in taenia coli
Immediately after isolation and determination of the wet weight, the taenia coli was frozen in liquid nitrogen and stored at − 80
• C. The taenia coli was thawed in 10 vol. of extraction buffer [12.5 % glycerol, 2 % SDS, 67.5 mM Tris/HCl (pH 6.8) and 5 % 2-mercaptoethanol], homogenized and incubated on ice for 1 h. Following centrifugation at 20 800 g for 10 min at 4
• C, the total protein content of the supernatant, referred to in the following as 'WME (whole muscle extract)', was determined using the Bradford assay kit (Bio-Rad Laboratories) using BSA as a standard. The proteins of the WME were separated by SDS/PAGE, transferred on to PVDF membranes and probed with a polyclonal anti-KRP antibody [22] . Three different concentrations of the WME were run for each taenia coli sample. In order to construct a calibration curve for KRP, on each gel three different concentrations of recombinant wt (wild-type) KRP were run. The amount of KRP in the tissue was interpolated from the linear range of the calibration curve. The molar content of the tissue was calculated assuming an extracellular space of 32 % as reported previously for taenia coli [45] . Densitometric scans of the MHC (myosin heavy chain) band indicated that the MHC content in intact and Triton-skinned taenia coli is similar.
Confocal microscopy of KRP-loaded fibres
To assess the loading of taenia coli fibres using confocal microscopy, recombinant human KRP was labelled in independent reactions either at the lysine residues or at the cysteine residues. Briefly, for labelling the ε-amino group of the lysine residues with Alexa Fluor ® 488 succinimidyl ester, the pH of KRP that was previously dialysed against PBS was increased by adding sodium bicarbonate (pH 9.0) to a final concentration of 0.1 M. Labelling efficiency was assessed by adding Alexa Fluor ® 488 succinimidyl ester dissolved in dimethylfluoride to KRP in either an 8.8-or 17.7-fold excess, assuming a 100 % activity of the label. The reactions were stopped by adding hydroxylamine (pH 8.5) to a final concentration of 0.15 M, followed by a 60 min incubation at room temperature. KRP was dialysed against 10 mM potassium phosphate (pH 6.5), 100 mM KCl, 5 mM EDTA and 1 mM DTT for labelling the cysteine residues with Alexa Fluor ® 488 C 5 maleimide. After dialysis, the phosphate concentration was adjusted to 50 mM using a 500 mM potassium phosphate stock solution (pH 6.0). In order to reduce the thiol groups, the DTT concentration was raised to 10 mM and the protein was incubated for 30 min at 37
• C. In order to prevent an interference of the excess DTT in the following reaction, the protein was subsequently dialysed with two buffer changes against 50 mM Tris (pH 7.5), 100 mM KCl, 1 mM EDTA and 0.1 mM DTT. A 3-fold excess of Alexa Fluor ® 488 C 5 maleimide was added and the mixture was incubated for 4 h at 18
• C. The reaction was stopped by adding 1 mM DTT. Unincorporated fluorescent dyes were removed by extensive dialysis against 10 mM Mops (pH 7.0), 20 mM NaCl, 1 mM MgCl 2 , 0.1 mM EGTA and 1 mM DTT.
Triton-skinned taenia coli fibres held isometrically were incubated for 40 min at room temperature with 10 μM labelled KRP in relaxing solution. Excess label was removed by washing the fibres twice for 2 min each in relaxing solution containing 10 μM non-fluorescent KRP. The specimens were fixed in 4 % paraformaldehyde for 30 min, washed twice with PBS and embedded in Mowiol 4-88. The staining of F-actin (filamentous actin) with Alexa Fluor ® 555 phalloidin was performed with 5 units of phalloidin per reaction. DAPI was used for the staining of nucleic acid. Fluorescent signals were detected by confocal microscopy on a Leica DMI 6000B microscope, using excitation wavelengths of 405 nm for DAPI, 488 nm for Alexa Fluor ® 488 and 561 nm for Alexa Fluor ® 555. The laser was operated with 16 % intensity at 405 nm, 22 % intensity at 488 nm and 18 % intensity at 561 nm.
Determination of rMLC phosphorylation in fibres
The extent of rMLC phosphorylation was determined using glycerol-urea electrophoresis [41] . In brief, the isometrically contracted fibres were immersed into ice-cold 15 % TCA (trichloroacetic acid) containing 5 % sodium pyrophosphate for 10 min at the desired times, and subsequently homogenized in the urea sample buffer containing 20 mM Tris/HCl (pH 6.8), 9 M urea and 10 mM DTT. The lysates were clarified from any residual material and subjected to glycerol-urea polyacrylamide gel electrophoresis, followed by Western blotting using the anti-20 kDa MLC primary antibody (dilution 1:200; Sigma), and the alkaline-phosphatase-conjugated secondary antibody (dilution 1:5000). The immunoreactivity of separated phosphorylated and unphosphorylated rMLC bands was detected with BCIP (5-bromo-4-chloroindol-3-yl phosphate) and NBT (Nitro Blue Tetrazolium) as chromagen reagents, and evaluated by scanning densitometry and Phoretix software. The fraction of phosphorylated rMLC was expressed as a percentage of the total rMLC.
Measurement of KRP phosphorylation in fibres during microcystin-induced contraction
The fibres were mounted isometrically on to stainless steel Utubes with Histoacryl and subjected to the same experimental protocol as described above for the force measurement experiments. The fibres were preloaded with 10 μM of the wt human KRP for 40 min, and then incubated for another 60 min with 10 μM microcystin in relaxing solution containing 3. 
Measurement of KRP dephosphorylation
Dephosphorylation of phosphorylated KRP in taenia coli was monitored by two approaches, namely directly in fibres or in the homogenates of taenia coli to which phospho-KRP was added as a substrate. To determine whether phosphorylated KRP becomes dephosphorylated in the fibres during the loading period, the fibres were mounted isometrically on to the stainless steel U-tubes with Histoacryl. Following a maximal contraction and relaxation cycle, the fibres were incubated for 60 min with 10 μM human KRP prephosphorylated by PKA or MAPK in relaxing solution and then fixed by immersion into TCA. As a control for the initial level of KRP phosphorylation, the fibres were incubated for 60 min with phospho-KRP and 10 μM microcystin in rigor solution [20 mM imidazole (pH 6.7), 2.5 mM magnesium acetate, 3 mM EGTA, 1 mM sodium azide, 50 mM KCl, 1 μM leupeptin and 2 mM DTT]. The level of KRP phosphorylation by MAPK or PKA was determined by SDS/PAGE and glycerol-urea gels respectively, with subsequent immunoblotting with antibodies against total KRP. To measure whether phosphorylated KRP can be dephosphorylated by tissue homogenates, the skinned fibres were homogenized in 5 vol. (w/v) of ice-cold rigor solution. Phospho-KRP (10 μM) was incubated for 40 min at 30
• C with the homogenate that was diluted with rigor solution to a final dilution of 1/10 (w/v). The initial phosphorylation level of phospho-KRP was determined in the presence of 10 μM microcystin as described above. Reactions were stopped by the addition of SDS sample buffer, and the proteins were resolved by SDS/PAGE. The level of KRP phosphorylation was determined by Western blotting using phospho-specific antibodies as described below.
SDS/PAGE and Western blotting
Fibres were fixed for 10 min with 15 % ice-cold TCA and washed with acetone. The removal of TCA was controlled by Bromophenol Blue in 20 mM imidazole buffer (pH 6.7). The fibres were homogenized on ice in SDS/PAGE sample buffer and heated for 5 min. Thereafter, urea was added to a final concentration of 5 M. The total protein concentration in the extracts was determined using the Bradford protein assay kit. Slab gels (10-15 %) were used for SDS/PAGE as described in [42] , and Western blot analysis against KRP species were performed as described previously [22] . The upper part of the gel was stained with Coomassie Blue R-250 as a loading control, the proteins in the lower part were transferred on to PVDF or nitrocellulose membranes which were blocked with 5 % nonfat skimmed milk in TBS [Tris-buffered saline (10 mM Tris and 150 mM NaCl, pH 8.0)], supplemented with 0.1 % Tween 20, and incubated with primary antibodies in 1 % non-fat skimmed milk in TBS containing 0.1 % Tween 20. As secondary antibodies, horseradish peroxidase-conjugated IgG or IR Dye ® 800CW (Li-COR) antibodies were used in dilutions recommended by the manufacturers. The protein bands were visualized and quantified by ECL (enhanced chemiluminescence; Pierce) and densitometric scanning using Phoretix software or the Odyssey Infrared Imaging System (Li-COR) respectively.
Statistics
The data were analysed using a Student's t test and are presented as means + − S.E.M. from n independent experiments. P < 0.05 was considered statistically significant.
RESULTS AND DISCUSSION
KRP inhibits the rMLC phosphorylation of HMM
We have suggested previously that KRP competitively inhibits rMLC phosphorylation by averting the docking binding of MLCK to its substrate, myosin [24, 26] . Additionally, KRP may shelter Ser 19 from phosphorylation by binding to myosin close to the rMLC-binding region, and thereby inhibit other rMLC kinases that do not possess the KRP domain or otherwise employ this noncatalytic docking interaction. This hypothesis was tested using the constitutively active 61 kDa tryptic fragment of MLCK (61K-MLCK), which lacks the C-terminal regulatory segment including the KRP domain and, hence, unlike full-length MLCK, does not bind to myosin [39] .
The recombinant avian His 6 -tagged KRP inhibited rMLC phosphorylation of HMM by both the full-length MLCK and the 61K-MLCK in a time-and concentration-dependent manner (Figure 1 ). KRP interestingly appeared to more effectively inhibit rMLC phosphorylation by the 61K-MLCK than by full-length MLCK. The reason for this difference is presently unclear. A probable explanation is that the 61K-MLCK, unlike full-length MLCK, does not compete with KRP for myosin binding. These results suggest that inhibition of rMLC phosphorylation is not confined to competition with MLCK docking to myosin. It is therefore conceivable that KRP also inhibits phosphorylation and tension development induced by the non-canonical Ca 2+ -independent rMLC kinases.
KRP inhibits Ca
2+ -independent contractions in Triton-skinned taenia coli fibres Triton-skinned taenia coli fibres, which have been widely employed to study the effect of exogenously added proteins on the regulation of the contractile mechanism (e.g. [31, 43] ), were used to investigate the effect of KRP on contraction because of the ease with which homogenous thin fibre bundles (∼ 100-200 μm in diameter) can be dissected. They are therefore well suited to allow the diffusion of proteins into the fibres and the vicinity of the myofilaments. However, the majority of research into the mechanism of microcystin-induced Ca 2+ -insensitive contractions has used vascular smooth muscle as a model system. Therefore we first determined whether microcystin elicits a Ca 2+ -independent contraction in Triton-skinned taenia coli that cannot be ascribed to activation of MLCK.
As shown in Figure 2 (A), addition of 10 μM microcystin-LR to the relaxing solution (pCa > 8) induced a sustained Ca 2+ -independent rise in force, which after 40 min amounted to 91 + − 1 % of maximum force (F max ) elicited at pCa 4.5. The tension rise was much slower than that induced by pCa 4.5, and was similar to previous reports for Triton-skinned vascular [5] and β-escin-permeabilized ileal smooth [8] muscle. The contraction was associated with an increase in rMLC monophosphorylation from its basal value of 2.8 + − 2.8 % to 38 + − 6.4 % (n = 4) and 43 + − 2.2 % (n = 9) at 10 and 25 min after microcystin application. Diphosphorylation of rMLC, which is considered to be a characteristic feature of the action of non-canonical rMLC kinases ( [36] , reviewed in [11] ), was not regularly observed in our experiments. The reason for this variability could be that rMLC phosphorylation was assessed during the rising phase of the contraction rather than at the plateau as in the previous investigations (e.g. [5, 8, 36] ). In the experiments in which diphosphorylation occurred, it ranged between 7 and 14 % of the total rMLC. A similar level of diphosphorylation was observed when myosin was phosphorylated by ILK in vitro [10] , whereas in Triton-skinned ileum, diphosphorylation amounted to 1.5 % of the total rMLC [8] . For comparison, in Tritonskinned rat caudal artery, microcystin-induced mono-and diphosphorylation, determined at steady-state force, was ∼ 30 % and ∼ 50 % of the total rMLC respectively [36] .
In keeping with previous investigations [5, 6, 8, 36] , the MLCK inhibitor wortmannin (10 μM) and the ROK (Rho kinase) inhibitor Y27632 (10 μM) failed to inhibit the microcystininduced Ca 2+ -independent contractions, whereas they were inhibited by the general protein kinase inhibitor staurosporine (2 μM) ( Figure 2A , compare with [6] ). Wortmannin, at the concentration used in the present study, inhibits not only fulllength MLCK, which could be activated by autophosphorylation [46] , but also its constitutively active Ca 2+ -independent fragment, which might be generated by proteolytic degradation in the Triton-skinned fibres [39, 46] . These results indicate that the Ca 2+ -independent contractions are not mediated by MLCK or ROK. Staurosporine has been shown to inhibit ZIP kinase [12] , one of the putative non-canonical rMLC kinases [11] . In smooth muscle, two forms of ZIP kinase were detected: a long 54 kDa and a shorter 32 kDa form (reviewed in [11] ). Western blot analysis of taenia coli using commercial antibodies revealed that the short ZIP kinase is expressed in this tissue and that it remains associated with Triton-skinned fibres ( Figure 2B , compare with [12] ). We also investigated whether the other putative noncanonical rMLC kinase, ILK, is expressed in taenia coli. ILK exists in two spatially distinct pools, a Triton-soluble membraneassociated and a Triton-insoluble pool [10] . The Triton-insoluble fraction associated with the myofilaments amounts to approx. 75 % of the total ILK in chicken gizzard smooth muscle [10] . Western blot analysis revealed that ILK is expressed in taenia coli and a significant amount is retained in the Triton-skinned fibres ( Figure 2C ). The lack of specific inhibitors has so far precluded the unequivocal identification of the kinase responsible for Ca 2+ -independent contractions [8, [10] [11] [12] . Nevertheless, as our results are in keeping with the previous reports, we propose that the Ca 2+ -insensitive contractions are due to either ZIP kinase or ILK or both.
Intact taenia coli, like other phasic smooth muscles [19] , contains a considerable amount of KRP amounting to 0.15 + − 0.02 mg/g of tissue wet weight which converts into 12.978 + − 1.45 μM (n = 8) assuming an extracellular space of 32 % [45] . Consistent with a previous report [32] , KRP is almost completely lost upon Triton skinning ( Figure 3A) , suggesting that KRP binds weakly to the myofilaments and therefore its relaxing effect is readily reversible [32] . MLCK, in contrast, is retained in the fibres, probably due to its binding to actin via the N-terminal domain, rather than due to docking of the KRP domain on myosin [35] .
Incubating Triton-skinned fibres with exogenous recombinant KRP restores the KRP content, as shown by SDS/PAGE. In order to distinguish between endogenous and exogenous KRP, human His 6 -tagged KRP, which has a lower electrophoretic mobility than the endogenous protein, was used ( Figure 3A) . Confocal microscopy of Triton-skinned fibres loaded with Alexa Fluor ® 488-labelled KRP shows the uniform distribution in the skinned fibres ( Figure 3B and Supplementary Figure  S1 at http://www.BiochemJ.org/bj/429/bj4290291add.htm). We note that the distribution of KRP cannot be detected by indirect immunohistochemistry in intact fibres because anti-KRP antibodies will obviously cross-react with MLCK in smooth muscle preparations. In conclusion, Triton-skinned taenia coli fibres can be used as an experimental model system allowing the analysis of the effect of exogenously added KRP on Ca 2+ -insensitive rMLC phosphorylation and contraction without the confounding effects of endogenous KRP.
In the KRP-loaded fibres, the microcystin-induced, Ca 2+ -independent contraction was significantly (P < 0.05) slowed down ( Figure 3C ). KRP thus increased the lag-phase from 2-3 min in the control fibres to ∼ 10 min, and the time to reach 50 % of F max from 8.4 + − 0.9 min (control) to 35.1 + − 2.5 min. The plateau of the contraction was not reached even after 40 min of incubation in microcystin. Hence, force at 40 min was 56 + − 4 % of F max (n = 7) in KRP-loaded fibres, which compares with 91 + − 1 % (n = 7) in the control fibres. The fibres were not contracted for longer times because a run-down of contraction was observed after incubation in microcystin for more than 40 min. KRP also reduced the microcystin-induced increase in rMLC phosphorylation from 43.1 + − 2.2 % (n = 9) to 33.5 + − 3.7 % (n = 8, P < 0.05) at 25 min after microcystin application ( Figure 3D ) suggesting that KRP inhibits Ca 2+ -independent force by inhibiting rMLC phosphorylation. The results shown here extend the observation of Sobieszek et al. [31] that KRP inhibits Ca 2+ -induced contractions. We note that our results are in contrast with a previous report [30] , but the reason for the diverging results is not clear at present.
Phosphorylated KRP inhibits microcystin-induced contraction with similar efficiency as the unphosphorylated KRP
As described in the Introduction, PKG-mediated phosphorylation of KRP at Ser 13 was suggested to potentiate its relaxing effect, whereas the functional significance of the phosphorylation of the MAPK site Ser 19 is not yet clear. It was therefore of interest to determine whether the inhibition of Ca 2+ -insensitive contractions is modulated by the phosphorylation of KRP. We tested this with different experimental approaches.
First, we determined whether unphosphorylated KRP becomes phosphorylated in the fibres during incubation with microcystin. This was important because inhibition of phosphatases by microcystin may not only unmask kinase activities directed towards rMLC, but also residual kinase activities directed towards KRP. These kinases are retained in Triton-skinned fibres. Cyclic nucleotides, for instance, have been shown to decrease Ca 2+ -sensitivity by phosphorylating endogenous substrates in Tritonskinned smooth muscle (e.g. [47] 19 were changed to alanines (AA-KRP) and therefore could not be phosphorylated in the skinned fibres was as effective in inhibiting microcystin-induced contractions as wt KRP.
In the next series of experiments, we determined whether phosphorylation of KRP modulates its inhibitory effect on HMM phosphorylation by 61K-MLCK and on Ca 2+ -independent contraction. KRP was pre-phosphorylated in vitro with PKA (at Ser 13 ) , MAPK (at Ser 19 ) or both kinases [27] . Each site was completely phosphorylated, as was evident from the mobility shift of phosphorylated KRP species on the urea and SDS gels ( Figure 4A ). Because these kinases may phosphorylate other substrates in smooth muscle [47] , they were removed from the KRP preparation to avoid confounding effects. HMM was fully phosphorylated within 3 min by 61K-MLCK. Recombinant KRP inhibited this reaction, consistent with the data shown in Figure 1 . Different from the experiments shown in Figure 1 , which were carried out at low ionic strength (20 mM) and with His 6 -tagged avian KRP, the experiments shown in Figure 4 were carried out with non-tagged human recombinant KRP at high ionic strength (150 mM) in order to match the conditions more closely to those in the fibre experiments. The observation that KRP inhibits HMM phosphorylation at high ionic strength is in keeping with our previous report that KRP binding to myosin exhibits little salt-dependence [26] . As shown in Figures 4(B) and 4(C), the different phosphorylated KRP species were equally effective in delaying rMLC phosphorylation as unphosphorylated KRP, indicating that phosphorylation of these N-terminal residues did not affect the ability of KRP to inhibit rMLC phosphorylation in vitro. Moreover, deletion of the N-terminal residues harbouring all of the phosphorylation sites had no effect on the inhibitory effect of KRP ( Figure 5 ).
In line with these in vitro data, phosphorylation of KRP did not modulate its inhibitory effect on Ca 2+ -independent contraction of the Triton-skinned fibres ( Figure 4D ). As phosphorylated KRP is loaded into the fibres in the absence of a phosphatase inhibitor, the possibility exists that it becomes dephosphorylated during the loading period. Control experiments showed that this was not the case. First, loading the fibres with phosphorylated KRP showed that the phosphorylation level of KRP was maintained in the skinned fibres ( Figure 4E ) and, secondly, incubation of phosphorylated KRP with lysates of Triton-skinned fibres did not lead to dephosphorylation of KRP (Supplementary Figure S3 at http://www.BiochemJ.org/bj/ 429/bj4290291add.htm). In addition, a phosphorylationmimicking mutant in which both serine residues were changed to aspartate residues inhibited contraction and rMLC phosphorylation with similar efficiency as the wt protein ( Supplementary Figure S4 at http://www.BiochemJ.org/bj/429/bj4290291add.htm). The important conclusions emerging from these results are that neither phosphorylation of the PKA/PKG site, nor phosphorylation of the MAPK site altered the inhibitory effect of KRP on Ca 2+ -insensitive contractions. Our findings differ from the previous observations that the relaxing effect of KRP was potentiated in Triton-skinned ileum in the presence of PKG, or its activator 8-bromo-cGMP, or when the N-terminal Ser 13 of KRP was mutated to mimic phosphorylation [30, 32] . If, however, as we did, KRP was directly phosphorylated at Ser 13 , inhibition by KRP remained unchanged [28] . This raises the interesting possibility that other PKG substrates in the fibres act in synergy with phosphorylated KRP. In this context it is worth remembering that ablation of KRP in the mouse . (E) Phosphorylated KRP is not dephosphorylated in the skinned fibres. Skinned fibres were incubated either without added KRP ('taenia') or with phosphorylated KRP ('taenia+P-KRP') for 60 min. Lysates were analysed by SDS/PAGE or urea-glycerol PAGE. The positions of KRP and phosphorylated KRP were identified by Western blotting using corresponding standards loaded on to lanes 1-3 as indicated. No mobility shift of phosphorylated KRP was observed after 60 min of incubation (taenia+P-KRP) indicating that it was not dephosphorylated. The electrophoretic mobility of this band remained exactly the same as that of phosphorylated KRP incubated with skinned fibres in the presence of 10 nM okadaic acid (taenia+P-KRP+OA) or 10 μM microcystin (taenia+P-KRP+MC) which were added in separate experiments to inhibit any potential dephosphorylation of KRP. For reference, the right-hand lane shows the migration of unphosphorylated KRP that was incubated with separate fibres. Equal loading was confirmed by staining the upper part of the gels with Coomassie Blue R-250. Representative results of two independent experiments are shown.
reduces cGMP-mediated Ca 2+ -desensitization by only 50 % [16] ; in other words, these other substrates contribute to ∼ 50 % of Ca 2+ -desensitization. Another level of complexity is added by the possibility that KRP or phosphorylated KRP may accelerate relaxation, and perhaps augment inhibition of contraction by interacting with these other substrates. Further studies are needed to identify KRP-binding partners and putative synergistic effects with other PKA/PKG substrates.
The C-terminus of KRP is required for the inhibition of rMLC phosphorylation and microcystin-induced contraction
Next we tested whether KRP has to bind to myosin in order to inhibit HMM phosphorylation by 61K-MLCK, as well Ca 2+ -insensitive contractions. As shown in Figure 5 , the truncated KRP ( C-KRP) lacking the acidic C-terminus known to confer strong binding to myosin [24, 34] , inhibited neither HMM phosphorylation by 61K-MLCK ( Figure 5A ), nor the microcystininduced contraction in skinned fibres ( Figure 5B ). The lag-phase was comparable with that in the control fibres, and force after 40 min of incubation with microcystin was 92 + − 2 % of F max in C-KRP-loaded fibres compared with 93 + − 3 % in control fibres (n = 5; P > 0.05). Furthermore, there was no significant decrease in the rMLC phosphorylation level in the presence of C-KRP determined at 25 min after microcystin addition ( Figure 5B, inset) . These results indicate that the C-terminal region of KRP is critical for the inhibition of rMLC phosphorylation and Ca 2+ -independent force development.
Putative mechanism of KRP action and physiological relevance
We have previously shown that KRP inhibits MLCK-mediated phosphorylation of myosin and HMM by competing with MLCK for the non-catalytic docking on myosin [24, 26] . However, this mechanism cannot explain the findings reported in the present study, namely that KRP inhibits the phosphorylation reaction mediated by the 61K-MLCK which lacks the docking KRP domain. It also cannot explain the inhibition of Ca 2+ -independent contractions because the non-canonical rMLC kinases most probably do not compete with KRP for binding to myosin, an assumption that awaits biochemical confirmation. On the other hand, myosin binding of KRP appears to be pivotal for this inhibition ( Figure 5 ). Therefore we propose that KRP interferes with the phosphorylation reaction by binding to the S1-S2 junction adjacent to rMLC thereby restricting the accessibility of Ser 19 . Although this novel mechanism is more general than that described above, it incorporates the competitive mechanism. It satisfactorily accounts for the inhibition of contraction and rMLC phosphorylation in skinned fibres elicited by novel non-canonical rMLC kinases.
In order to operate through this myosin-based mechanism, KRP needs to be expressed at a high molar ratio of KRP to myosin. In vitro KRP binds with a 1:1 stoichiometry to myosin [24] . The cellular concentration of myosin for non-arterial smooth muscle was reported to be 19.5 mg/g of cell wet weight [48] converting into a cellular concentration of ∼ 40 μM based on a molecular mass of 480 kDa, whereas in portal vein, the myosin head concentration was reported to be 52 μM converting into 26 μM myosin [21] . On the basis of these values and our determination of the cellular KRP content of ∼ 13 μM, a molar ratio of KRP to myosin ranging from 1:3 to 1:2 can be calculated. In solution KRP binds to unphosphorylated myosin with a K d of 5.5 μM converting into a KRP-myosin complex of 10-11 μM. In other words, ∼ 27-37 % of myosin in the fibres could be occupied by KRP in intact taenia coli. It is reasonable to suggest that our experimental conditions mimic the molar ratio of KRP to myosin because the MHC content in skinned taenia coli was similar to that in intact taenia coli (Figure 2) . In other types of phasic smooth muscle (ileum, portal vein) the molar ratio of KRP to myosin is probably higher because their reported KRP content was ∼ 2-fold higher [21] . Hence, the KRP content in phasic smooth muscle is sufficient to inhibit contraction by this novel myosin-based mechanism.
Our results in conjunction with those of other laboratories [16, 21, [30] [31] [32] suggest that KRP functions dually in smooth muscle, i.e. it inhibits contraction and accelerates relaxation. The latter effect has been ascribed to the activation of MLCP activity, whereby the mechanism remains elusive [16, 32] . This dual action is supported by biochemical experiments using so-called native myosin and actomyosin, which both possess endogenous MLCK, calmodulin and MLCP activities [31] . In this preparation, the addition of Ca 2+ and ATP resulted in a biphasic phosphorylation progress curve, where a rapid increase in rMLC phosphorylation was followed by a decline to baseline levels once ATP was depleted by myosin ATPase. KRP decelerated the rate of phosphorylation, whereas it accelerated the rate of dephosphorylation. The authors proposed that MLCK and rMLC phosphatase form a complex on myosin filaments, and KRP alters its composition by binding to myosin and liberating MLCK. This shifts the balance in favour of the remaining phosphatase. Although this hypothesis may provide a mechanistic explanation for the increase in the apparent MLCP activity, our findings suggest that disruption of this complex is not necessary for the inhibition of rMLC phosphorylation. This is because KRP inhibition of rMLC phosphorylation appears to be non-selective for MLCK and occurs with soluble HMM, i.e. it does not require the filamentous state of myosin.
In these two functions, the C-terminal and N-terminal segments of KRP, which flank a large central seven-sheet barrel of a C2 immunoglobulin-like motif [23] , may play different roles, as shown in Figure 6 . The N-terminal segment was not The ribbon diagram shows the core of a KRP molecule that adopts a seven-sheet β-barrel conformation [23] . The thread-like terminal sequences denoted by N and C are introduced in freestyle, as they were not resolved in the crystal structure. The N-terminal sequence is suggested to mediate, in a phosphorylation-dependent manner, the acceleration of smooth muscle relaxation and rMLC dephosphorylation, possibly via activation of rMLC phosphatase [16, 26] . The C-terminal sequence, which mediates myosin binding of KRP [34] , is critical for the inhibition of rMLC phosphorylation and the development of Ca 2+ -independent force as shown in the present work. See the text for further details.
required for inhibition of HMM phosphorylation ( Figure 5 ), but phosphorylation of certain N-terminal residues may modulate the realxing effect of KRP. In contrast, the C-terminal segment was required for the inhibition of rMLC phosphorylation in vitro and in skinned fibres, as well as force development (the present study), but not for the acceleration of relaxation [30] .
At present, we can only speculate about the physiological relevance of our findings. Moreover, the physiological function of the non-canonical rMLC kinases is still not fully understood, but they are thought to play a role in Ca 2+ -sensitization, in the regulation of tension maintenance at low levels of [Ca 2+ ] [11] and in contraction of certain types of smooth muscle [7] . On the basis of our findings it is possible that KRP plays a role in regulating basal rMLC phosphorylation and tone through the mechanism described in the present study. It could also prevent accidental rMLC phosphorylation at low spurious levels of rMLC kinase activity, thereby setting the threshold for activation. High levels of rMLC phosphorylation, i.e. when the muscle is fully activated, prevent the binding of KRP to myosin [26] . Under this condition, KRP may decrease rMLC phosphorylation and force by increasing the apparent activity of MLCP. This dual mechanism may allow KRP to act as a brake, irrespective of the degree of smooth muscle activation. Studies using intact smooth muscle from KRP-deficient mice [16] may help to unravel the physiological function of KRP.
Summary
In summary, we report for the first time in the present paper that KRP inhibits the Ca 2+ -independent phosphorylation of rMLC and force development in Triton-skinned smooth muscle, which is most probably mediated by non-canonical rMLC kinases, such as ZIP kinase and/or ILK. Binding of KRP to myosin is critical for the inhibitory effect, because a KRP mutant which is deficient in myosin binding failed to inhibit rMLC phosphorylation and contraction. Inhibition of the Ca 2+ -independent contraction is not modulated by phosphorylation of the N-terminal residues Ser 13 (PKA), Ser 19 (MAPK) or both. As we removed the enzymes prior to loading of the fibres with the pre-phosphorylated KRP species, the results are not confounded by phosphorylation of other PKA or MAPK substrates in the fibres. Control experiments showed that the phosphorylation status of KRP was not altered in the fibres. In keeping with these fibre experiments, full-length, but not the C-terminally truncated, KRP inhibited phosphorylation of HMM by the 61K-MLCK. Inhibition of HMM phosphorylation by full-length KRP was indpendent of the N-terminal phosphorylation status. The results of the present study extend previous observations that KRP inhibits Ca 2+ -induced force in Triton-skinned fibres, as well as HMM phosphorylation in vitro by the conventional MLCK, and provide strong evidence that KRP is a more general inhibitor of smooth muscle contractility. As the 61K-MLCK lacks the C-terminal domain which conveys docking binding to myosin, displacement of MLCK from the noncatalytic binding to myosin is not a prerequisite for inhibition of rMLC phosphorylation. On the other hand, binding of KRP to myosin is critical for inhibition. We therefore propose that KRP inhibits rMLC phosphorylation by shielding rMLC from being phosphorylated by the dedicated MLCK, as well as non-canonical rMLC kinases.
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Figure 2 KRP was not phosphorylated in skinned fibres during microcystininduced contraction
Triton-skinned taenia coli fibres were incubated with KRP and microcystin in the presence of [γ -
32 P]ATP, as detailed in the Experimental section of the main text. Lysates of the fibres and isolated KRP pre-phosphorylated in vitro, with MAPK as a standard, were subjected to SDS/PAGE. The upper part of the gel was stained with Coomassie Blue R-250 (top panel) as a loading control, whereas the proteins from the lower part were transferred on to PVDF membranes followed by autoradiography to determine 32 P incorporation (middle panel), and Western blot analysis with anti-KRP antibodies (bottom panel). Lanes 1-4, increasing amounts of recombinant pre-phosphorylated KRP (5, 10, 15 and 20 ng); we note that phosphorylated KRP has a lower mobility than unphosphorylated KRP. Lane 5, skinned fibres incubated with microcystin without KRP; and lane 6, wt-KRP. No 32 P incorporation into protein bands corresponding to KRP can be detected in the fibres. In vitro phosphorylated KRP that served as a standard showed that 32 P incorporation could already be detected when only 5 ng of the protein is loaded (lanes  1-4) . Notably, this is 4-fold less than the KRP content in the fibres (>20 ng of KRP per lane), indicating that recombinant KRP is hardly, if at all, phosphorylated when incubated with fibres. Representative results of three independent experiments are shown. The molecular mass in kDa is indicated on the right-hand side. The phosphorylation level of KRP was assessed by Western blotting of the lower parts of the gels using phosphorylation-and site-specific anti-KRP antibodies and ECL detection. The upper parts of the gels were stained with Coomassie Blue to verify equal loading. To visualize the initial level of KRP phosphorylation, 10 μM microcystin was separately added to the control reaction (Mc) and half of this sample (1/2 Mc) was also applied to check for the linearity of the ECL signal and aid quantification.
